​

Chemed (CHE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CHE Stock Forecast

Chemed (CHE) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $635.00, with a high of $650.00 and a low of $620.00. This represents a 20.25% increase from the last price of $528.05.

$350 $410 $470 $530 $590 $650 High: $650 Avg: $635 Low: $620 Last Closed Price: $528.05

CHE Stock Rating

Chemed stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (50.00%), 5 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 5 5 Strong Sell Sell Hold Buy Strong Buy

CHE Price Target Upside V Benchmarks

TypeNameUpside
StockChemed20.25%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks10.43%

Price Target Trends

1M3M12M
# Anlaysts123
Avg Price Target$620.00$635.00$581.67
Last Closing Price$528.05$528.05$528.05
Upside/Downside17.41%20.25%10.15%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 26-32--5
Oct, 26-23--5
Sep, 26-13--4
Aug, 26-13--4
Jul, 26-13--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 28, 2026Brian TanquilutJefferies$620.00$506.4622.42%17.41%
Sep 25, 2026UBS$650.00$495.6531.14%23.09%
Jan 22, 2026Brian TanquilutJefferies$475.00$453.534.73%-10.05%
Sep 02, 2025Jefferies$550.00$464.0018.53%4.16%
Nov 05, 2024Frank MorganRBC Capital$633.00$534.4118.45%19.88%
May 21, 2024Frank MorganRBC Capital$697.00$564.3423.51%32.00%
Apr 28, 2022RBC Capital$592.00$492.2520.26%12.11%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2026RBC CapitalSector PerformSector Performhold
Oct 29, 2026UBSBuyBuyhold
Oct 29, 2026OppenheimerOutperformOutperformhold
Oct 28, 2026JefferiesHoldBuyupgrade
Sep 25, 2026UBSBuyinitialise
Jul 31, 2026OppenheimerOutperformOutperformhold
Jul 30, 2026RBC CapitalSector PerformSector Performhold
Jul 29, 2026Bank of America SecuritiesNeutralNeutralhold
Apr 27, 2026RBC CapitalSector PerformSector Performhold
Feb 26, 2026Bank of America SecuritiesCautiousdowngrade

Financial Forecast

EPS Forecast

$15 $18 $21 $24 $27 $30 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$17.14$16.72$18.11$20.10$18.42--
Avg Forecast$19.16$19.67$20.71$23.08$24.89$26.32$28.18
High Forecast$19.21$19.83$20.92$23.12$25.34$26.59$28.47
Low Forecast$19.10$19.55$20.56$23.04$24.43$26.13$27.98
Surprise %-10.54%-15.00%-12.55%-12.91%-25.99%--

Revenue Forecast

$2B $2B $2B $3B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.14B$2.13B$2.26B$2.43B$2.53B--
Avg Forecast$2.14B$2.13B$2.27B$2.43B$2.60B$2.72B$2.87B
High Forecast$2.15B$2.15B$2.28B$2.45B$2.62B$2.75B$2.90B
Low Forecast$2.14B$2.13B$2.25B$2.41B$2.58B$2.71B$2.86B
Surprise %-0.10%0.00%-0.03%0.16%-2.65%--

Net Income Forecast

$150M $210M $270M $330M $390M $450M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$268.55M$249.62M$272.51M$302.00M$265.24M--
Avg Forecast$248.17M$273.69M$272.51M$350.82M$378.25M$400.66M$428.34M
High Forecast$297.81M$328.42M$327.01M$351.42M$385.11M$404.12M$432.76M
Low Forecast$198.54M$218.95M$218.01M$350.21M$371.39M$397.21M$425.36M
Surprise %8.21%-8.79%--13.92%-29.88%--

CHE Forecast FAQ

Is Chemed stock a buy?

Chemed stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Chemed is a favorable investment for most analysts.

What is Chemed's price target?

Chemed's price target, set by 10 Wall Street analysts, averages $635 over the next 12 months. The price target range spans from $620 at the low end to $650 at the high end, suggesting a potential 20.25% change from the previous closing price of $528.05.

How does Chemed stock forecast compare to its benchmarks?

Chemed's stock forecast shows a 20.25% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (10.43%).

What is the breakdown of analyst ratings for Chemed over the past three months?

  • November 2026: 0% Strong Buy, 60.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 0% Strong Buy, 40.00% Buy, 60.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.

What is Chemed’s EPS forecast?

Chemed's average annual EPS forecast for its fiscal year ending in December 2026 is $26.32, marking a 42.89% increase from the reported $18.42 in 2025. Estimates for the following years are.

What is Chemed’s revenue forecast?

Chemed's average annual revenue forecast for its fiscal year ending in December 2026 is $2.72B, reflecting a 7.65% increase from the reported $2.53B in 2025. The forecast for.

What is Chemed’s net income forecast?

Chemed's net income forecast for the fiscal year ending in December 2026 stands at $400.66M, representing an 51.06% increase from the reported $265.24M in 2025. Projections indicate .